MediPrint Ophthalmics Expands Clinical Program for Contact Lens D
05 Mar 2025 //
BUSINESSWIRE
MediPrint Advances Glaucoma Program & Expands Patent Portfolio
06 Feb 2025 //
BUSINESSWIRE
MediPrint Ophthalmics Presents Phase 2b LL-BMT1 Data for Glaucoma
12 Nov 2024 //
BUSINESSWIRE
MediPrint Ophthalmics Announces It Has Initiated Its SIGHT-2 Phase 2b
08 Nov 2022 //
BUSINESSWIRE